• stumble
  • youtube
  • linkedin

Archives for : $500 million

#India – Faking Happiness is forced to Present the ‘ VEDANTA ANTHEM” #HipHop #mustshare




An Indo-German collaboration with production by the talented DJ BC from Germany and the lyrics and vocals by A-List from India. A List is a raptivist and a member of Faking Happiness campaign. This track is a quick freestyle in response to Vedanta trying to salvage it’s reputation by sponsoring , NDTV‘S ”  Our Girls Our Pride ” , a  PR Exercise and a desperate attempt to salvage themselevs after they were kicked out  by the Gramsabhas and after attempting to exploit the Dongria Kondh  tribal community in Odhisa for the Niyamgiri Hills.


Pic- courtesy Down to Earth

It has been learnt that Mining Giant Vedanta, is shitting  in their pants after  their exposure by  Faking Happiness: Activists Strike Back at Vedanta Ad Campaign, which was such a huge set back. Recently , after they were Kicked out in a Match of 12-0, by the Dongria Kondh ,  tribal of Odisha, they have once again planned a Corporate social responsibility ( CSR)  campaign, called ‘Our Girls our pride and once again, we are back with a   BANG.


Our two petitions  to NDTV and Priyanka Chopra haS crossed the 2500 mark, do sign if you have not so far, if you have not  ?





Faking Happiness also  sent birthday wishes wishes Happy Birthday Dr Prannoy Roy – Withdraw Vedanta #ourgirlsourpride

So, Now Vedanta, CSR initiative is in a soup , as many  Craetive Faces with Political Voices, join Faking Happiness Anti Vedanta Campaign , and the voices are increasing every day

Hence, what they did ?

 They kidnapped, our very own , Ashwini Mishra aka A-list while he was  recording at his studio, and  coerced him to  to sing the ‘ VEDANTA ANTHEM “, they wanted to tell world that…… they will not take their defeat down and here are the lyrics—-

We are Vedanta, everywhere that we go,
Faking Happiness, you know how we roll,
We are Vedanta, everywhere that we go,
Faking Happiness, you know how we roll,
That’s right, this is the Vedanta anthem,
All the corporate greedy people chant them,
That’s right, this the Vedanta anthem,
All the corporate greedy people anthem,
That’s right, let’s go ahead and do this,
We thought we’d put our corporate greed to some music,
And tell you exactly where we come from,
Come on man, this is not a protest, this not a dumb song,
You see we kidnapped A-List, he’s in the back,
So Vedanta rep could come here and rap,
And tell you the truth,
That is the youth,
That needs to understand this is so much more than booth,
Listen to this, let the world know,
Matter of fact, for the girls though,
Let’s really talk about ‘coz the world dies,
When we build a mine, but we do the girl child,
We do a program for them on NDTV,
And now look, all these emcees be free,
But they never really talk about what we do,
“Coz corporate sponsorship taken, BOOM!
Now what you gonna do, what you gonna say,
‘Coz we do this like every single day,
Exploiting poor people like it is fun,
Actually it is when that shit has done

This is Vedanta and this is our anthem,
All the corporate greedy people chant them,
This is Vedanta and this is our anthem,
All the corporate greedy people chant them

That’s right, ain’t this a crazy world,
We are evil but we got Desi Girl,
That’s right, we got Priyanka Chopra to endorse us,
Now we got all kinds of endorsements,
All sorts of people saying that it’s cool,
What they did in the past, but they sent kids to school,
But hear the truth, we didn’t send anyone though,
That’s right, and that’s how we get through the flow,
That’s right, yo, this is such a crappy fest,
We make an art form out of  faking happiness,
And that’s us, that’s the Vedanta anthem,
All the corporate greedy people chant them,
And yo, you know Niyamgiri’s ill,
And we will come back, we will take Niyamgiri Hill,
And all the tribal people who had opposed us,
Come on man, you had proposed us
To be gone, but we will be back,
And when we come, we will come, we will be wrath,
We will buy over the police and the army,
That’s right, I’m rich, tell me who’ll harm me,

Vedanta Signing Out.



Niyamgiri hills, home to 8,000-odd Dongria Kondhs, tribal group, a few hundred Kutia Kondhs and other forest-dwellers who eke out a living cultivating pulses, paddy and collecting naturally-grown horticultural crops, is considered sacred by the indigenous tribes and others as it is the abode of Niyamraja – their presiding deity.

Ministry of Environment and Forests (MoEF) had rejected (Stage-II /final approval) Forest Clearance on 24.8.2010 for the Bauxite mining on the basis of issues outlined by the Forest Advisory Committee which stated that ‘the Primitive Tribal Groups were not consulted in the process of seeking project clearance and also noticed the violation of the provisions of Forest Rights Act, the Forest (Conservation) Act, 1980, Environmental Protection Act, 1986 and also the impact on ecological and biodiversity values of the Niyamgiri hills upon which the Dongaria Kondh and Kutia Kondh depend’ and the detailed report of Naresh Sexana Committee specially appointed to look into the issue. This MoEF Order was challenged in a petition at the Supreme Court of India by Orissa Mining Corporation.

The Supreme Court of India had decided on 18 April 2013 that if Bauxite Mining Project of Vedanta affects the religious right of Schedule Tribes and other Traditional Forest Dwellers like Dongaria Kondh, Kutia Kandha and others over the Niyamgiri hills in Odisha ‘right has to be preserved and protected’. The Court has left it to the Gram Sabhas to decide if such right is affected by the proposed mine.cts.

In India  first time an environmental referendum was conducted on a directive by the Supreme Court to find out whether mining in Niyamgiri will tantamount to an infringement of the religious, cultural, community and individual rights of local forest-dwellers. During July-August this year, 12 gram sabhas, selected by the Odisha government for the referendum on mining in Niyamgiri hills, had rejected the proposal. The tribal villages, located on the hill slopes, are part of Rayagada and Kalahandi districts.


1.   The first  village council  was held at Serakpadi village of Raygada district.  In the sabha 36 out of 38 voters in the first Palli Sabha in Niyamgiri have voted against mining in Niyamgiri.

2.T he second, three hour long ,  village council meeting at Kesarpadi in Rayagada district-, in which -Thirty-three of 36 eligible voters , including all 23 women, voted against bauxite mining……At the three-hour-long sabha, 33 of 36 adult voters from Kesarpadi  unanimously adopted a resolution as per the Forest Rights Act, conveying their opposition to mining in the Niyamgiri hills.

3  The third village council meeting was held in a non -tribal forest hamlet of Tadijhola, which is imporant note also  unanimously rejected proposed bauxite mining in the Niyamgiri hills t.Nineteen of the 22 voters in the village were present  including eighty-seven year old Sugri Gouda. Hard of hearing and barely able to stand on her own, she insisted on signing the resolution before leaving the meeting venue. Three bare words she uttered drew a cheer from those present: “Niyamgiri dibu nai” (won’t give up Niyamgiri). Gauda was the also most sought after by media, with a slew of video cameras following her fragile steps as a family member walked her home.

4.  The villagers of Kunakeda, a Dongaria Kondh village in Kalahandi district, today unanimously rejected the proposal for mining in Niyamgir..All 21 out of 22 voters, who attended the meeting, voiced their opposition to Vedanta .

5  The 5th village coucil meeting w s held at Palberi, where .Fifteen of the 16 adult voters from the forest village were in attendance. and voted out vedanta.


6 The sixth Pali sabha , Batudi rejected settlement of community forest claims in Niyamgiri ,  31 among 40 voters from the hamlet in attendance, also rejected a joint verification report to settle community and religious rights to the forests granted under the Forest Rights Act of 2006.

7  The seventh village council , Phuldumer – again voted unanimously to reject Vedanta’s mine.—49 of the 65 listed voters were present to voice their opinion, in the meeting.

8  Ijurupa  village council meeting was a CLASSIC ,  where there is just a famiily, and the  four  members of te family nailed down a 72 MT mining proposalvillage in Kalahandi district, Odisha

9   At Lamba ninth pallisabha ,Braving intermittent rain, the 38 voters in the remote village, ousted Vedanta

10.The largest village council fo 12 villages , Lakhpadar village under Kalyansinghpur of Rayagada district located on the slopes of Niyamgiri, the 97 Dongaria Kondhs present in the pallisabha unanimously rejected the proposal to mine the hills for bauxite.

11. Khambasi village in Rayagada district , was the  the eleventh palli sabha , which  also unanimously opposed Vedanta

12-   On August 19th In Jerapa, 16 out of 26 voters, including 10 women, gathered at the final Palli Sabha on Niyamgiri. Under heavy police presence, and in heavy rain, they repeated the statements given in previous meetings – that they opposed the mine and would not leave the mountain no matter what. The twelve voters said they were ready to face bullets to prevent the digging of their sacred mountain.

On August 19th, NDTV and VEDANTA LAUNCHED the ‘ our girls our pride’ campaign. Coincidence ?


While our friends at  FOIL VEDANTA protested on the streets of london , On August 1st at the AGM  of Vedanta , When asked about Lanjigarh refinery and the scandal that is the attempted Niyamgiri mine, Anil Aggarwal ,  responded with a dreamy speech about believing that Niyamgiri was meant for Vedanta. he talked about hearing about Kalahandi as a child – a ‘black spot’ on India, and its ‘poorest poorest place’, and how he’d always wanted to do something about it. He said:

“We took courage to go there, no road even or bridge, it was all isolated, we created infrastructure, 7000 got work, not a blade of grass was moved in Niyamgiri .”







Enhanced by Zemanta

Related posts

Ranbaxy’s fraudulent practices- A deception most foul #Healthcare #Pharma

A deception most foul

  • Ranbaxy tablet.
    Ranbaxy tablet.
Ranbaxy’s fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S.

Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world’s largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines.

Much has since been said about Ranbaxy’s attempts to wipe the slate clean and institute rigorous testing standards across the board, including Ranbaxy CEO Arun Sawhney’s comment that the “announcement marks the resolution of this past issue,” and his company was “pleased to continue bringing safe, effective and quality medicines to market for the benefit of consumers in the U.S. and other parts of the world.”

Yet, what has been commented on far less after Ranbaxy’s deception came to light is that the lives of millions in India, Africa, the U.S. and elsewhere, who place their faith in national regulators, may have been jeopardised by their consumption of adulterated drugs.

Elusive answers

Why has Ranbaxy been permitted to continue its U.S. operations? Why have the former owners of the company, brothers Malvinder and Shivinder Singh, been permitted to walk free with the $2 billion that they made from selling Ranbaxy to Daiichi Sankyo in 2008?

Finally, few, if any, fingers have been pointed at regulators in India for permitting a fraud of such breathtaking magnitude to occur under their noses, and allowing the venality of a single corporate entity to bring disrepute to “third world generics.”

Three points

Let us set the record straight then, and consider three key facts about this episode. In doing so, we will borrow from one analytic account that has put truth-telling and hard research over sound-bites and euphemisms, Katherine Eban’s “Dirty Medicine” exposé in CNN Money/Fortune.

First, Ranbaxy’s fraud permeated multiple levels of the organisation and its perpetrators’ actions have created a veritable spectrum of health dangers for the public.

Whistleblower and former Ranbaxy Director Dinesh Thakur was a key informant in the case who gave evidence, for example, that Ranbaxy scientists were routinely directed to “substitute cheaper, lower-quality ingredients in place of better ingredients, to manipulate test parameters to accommodate higher impurities, and even to substitute brand-name drugs in lieu of their own generics in bio-equivalence tests to produce better results.”

That Ranbaxy lied to the U.S. FDA and other regulators frequently, and indulged in back-dating and forging data, Mr. Thakur found, was “common knowledge among senior managers of the company, heads of research and development, people responsible for formulation to the clinical people.”

Sometimes it appeared that sheer insensitivity to the plight of clients consuming their dubious products had crossed all bounds.

Another senior official who quit Ranbaxy after her attempts to get management to curb the malpractice failed was Kathy Spreen. On one occasion when Dr. Spreen mentioned her concerns about the quality of Ranbaxy’s AIDS medicines for Africa an executive reportedly said, “Who cares? It’s just blacks dying.”

Second, U.S regulators have at best achieved a pyrrhic victory as the deal they have struck with Ranbaxy still leaves consumers at risk, does not result in charges against a single company official.

Despite several incriminating prior investigations of Ranbaxy plants in Dewas and Paonta Sahib in 2006, the FDA “did nothing to stop all the drugs that were already on the market, drugs that had been approved, or applications submitted from other sites,” Ms. Eban notes.

In February 2009, the FDA finally deigned to punish Ranbaxy by imposing an Application Integrity Policy, which effectively closed down Ranbaxy drug applications.

Yet, in November 2011, it did not see fit to hold Ranbaxy back from selling generic Lipitor, the popular cholesterol-reducer.

Blessed with a six-month exclusivity grant from the FDA, Ranbaxy went on to rake in a cool $600 million through atorvastatin sales.

Ultimately, fate intervened and, in November 2012, Ranbaxy had to issue a massive recall notice for atorvastatin after glass particles were discovered in samples. The FDA backed off from any suggestion that it may have bungled its approvals process for Ranbaxy.

The India angle

Third, Indian regulators’ monumental failure to address Ranbaxy’s malaise early on has only been compounded by its unwillingness to take strong steps, even at this late stage, to bring the company to justice in Indian courts and save millions of its citizens from avoidable harm.

The media must share blame for not keeping the government’s nose to the grindstone. After Ranbaxy’s knuckles were notionally rapped earlier this month the press has displayed a staggering lack of interest in the core issue, the damage that Ranbaxy’s products have likely caused to Indians and the government’s role in that.

One major newspaper proclaimed, “The good news is that the company’s U.S. revenues, after dipping post-2008 for a couple of years, have now started recovering [sic].” Another declared, “Despite all the noise, the overwhelming majority of generic drugs are as safe and effective as their brand-name counterparts. Brand-name companies have also had their share of quality problems.” It is inconceivable with all the brouhaha about intensifying U.S.-India co-operation that New Delhi could have been entirely in the dark since 2006, when questions were first raised about Ranbaxy in the U.S. What were India’s Ministry of Health and Drug Controller General doing since then?

Even as late as last week, the Ministry’s Joint Secretary Arun Panda was on record saying “There is no order from the health ministry which has been issued to Drug Controller General of India to launch a probe against the company as of today.”

One can only wonder what further evidence against Ranbaxy officials hoped to obtain when one of them said, “Launching a probe against a company is a serious matter and a decision to that effect would be taken after due consideration of all aspects in the Ranbaxy case.”

Coming as it does after the Supreme Court’s landmark decision in the Novartis Glivec case, the government’s inaction hardly helps the cause of the generics business. Now we should expect influential branded-drug manufacturers to redouble their lobbying efforts to get lawmakers to block the rising tide of generic alternatives.

Similar to high-level corruption cases it may be that the government will respond adequately only when there is a surge of public protest. Otherwise, the next time you fall ill, the prescription may well be glass particles.

[email protected]


Related posts